Retrospective Study
Copyright ©The Author(s) 2020.
World J Gastroenterol. Sep 7, 2020; 26(33): 4960-4971
Published online Sep 7, 2020. doi: 10.3748/wjg.v26.i33.4960
Figure 4
Figure 4 Time-course changes from baseline to 12 mo of denosumab treatment. A: In the levels of serum tartrate-resistant acid phosphatase 5b; B: Serum procollagen type N-terminal propeptide; C: Serum calcium; and D: Plasma pentosidine. aP < 0.001 vs baseline.